Aura Biosciences (AURA) Interest Coverage Ratio (2020 - 2026)
Aura Biosciences (AURA) posted Interest Coverage Ratio of 1.48 for Q1 2026, up 95.42% on a QoQ basis from 32.39 in Q4 2025, and up 86.74% year-over-year from 0.79 in Q1 2025.
Aura Biosciences (AURA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Aura Biosciences' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 1.48 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 86.74% year-over-year to 1.48 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.05 (up 87.26% YoY) and the FY2025 annual result came in at 34.12, down 186.38% from the prior year.
- Interest Coverage Ratio was 1.48 for Q1 2026 at Aura Biosciences, up from 32.39 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.21 in Q1 2022 and bottomed at 34.04 in Q4 2024.
- A 5-year average of 8.78 and a median of 1.79 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 99.69% — and 2023, when it slumped 636.27%.
- Aura Biosciences' Interest Coverage Ratio stood at 22.93 in 2022, then slumped by 36.27% to 31.25 in 2023, then fell by 8.91% to 34.04 in 2024, then increased by 4.85% to 32.39 in 2025, then soared by 95.42% to 1.48 in 2026.
- Business Quant data shows AURA's Interest Coverage Ratio at 1.48 in Q1 2026, 32.39 in Q4 2025, and 3.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | -1.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.48 |
| Dec 31, 2025 | -32.39 |
| Sep 30, 2025 | -3.75 |
| Jun 30, 2025 | -1.10 |
| Mar 31, 2025 | -11.18 |
| Dec 31, 2024 | -34.04 |
| Sep 30, 2024 | -2.11 |
| Jun 30, 2024 | -0.79 |
| Mar 31, 2024 | -2.90 |
| Dec 31, 2023 | -31.25 |
| Sep 30, 2023 | -1.79 |
| Jun 30, 2023 | -0.95 |
| Mar 31, 2023 | -1.53 |
| Dec 31, 2022 | -22.93 |
| Sep 30, 2022 | -0.37 |
| Jun 30, 2022 | -0.51 |
| Mar 31, 2022 | -0.21 |
| Dec 31, 2021 | -76.49 |
| Sep 30, 2021 | -0.63 |
| Mar 31, 2021 | -67.35 |